Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

KOSDAQ/042520 stock hub

KOSDAQ/042520 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/042520is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
359.4B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/042520
In the news

Latest news · KOSDAQ/042520

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.7
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-41.7
P25 n/aP50 n/aP75 n/a
ROIC-30.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/042520 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
184
Groups with data
11
Currency
KRW
Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
South Korea
Country code
KR
Employees
297
Enterprise value
KRW 386.6B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
KRW 359.4B
Price
KRW 25,200
Price currency
KRW
Rev Per Employee
337,271,250.3x
Sic
2836
Symbol
kosdaq/042520
Website
https://www.hansbiomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-7.64%
EV Earnings
-14.09x
EV/FCF
-14.96x
EV/Sales
3.86x
FCF yield
-7.19%
Forward P/E
23.72x
P/B ratio
5.07x
P/S ratio
3.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-25.27%
EBITDA Margin
-20.32%
Gross margin
58.62%
Gross Profit
KRW 58.7B
Gross Profit Growth
16.17%
Gross Profit Growth Q
60.14%
Gross Profit Growth3 Y
7.7%
Gross Profit Growth5 Y
6.89%
Net Income
KRW -27.4B
Pretax Margin
-26.79%
Profit Margin
-27.4%
Profit Per Employee
KRW -92.4M
ROA
-12.16
Roa5y
-4.93
ROCE
-31.49
ROE
-41.69
Roe5y
-30.76
ROIC
-30.27
Roic5y
-12.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
2.65%
Cagr15y
16.6%
Cagr1y
258.27%
Cagr3y
17.84%
Cagr5y
11.84%
Div CAGR3
6.27%
Div CAGR5
3.71%
Revenue Growth
24.2x
Revenue Growth Q
52.27x
Revenue Growth3 Y
9.17x
Revenue Growth5 Y
4.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
KRW 0.77
Assets
KRW 141.2B
Cash
KRW 15.9B
Current Assets
KRW 70.7B
Current Liabilities
KRW 60.8B
Debt
KRW 43.2B
Debt Equity
KRW 0.61
Debt FCF
KRW -1.67
Equity
KRW 70.9B
Interest Coverage
-13.85
Liabilities
KRW 70.3B
Long Term Assets
KRW 70.6B
Long Term Liabilities
KRW 9.5B
Net Cash
KRW -27.3B
Net Cash By Market Cap
KRW -7.58
Net Debt Equity
KRW 0.38
Tangible Book Value
KRW 70.5B
Tangible Book Value Per Share
KRW 4,947
WACC
13.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.16
Inventory Turnover
1.39
Net Working Capital
KRW 30B
Quick ratio
0.6
Working Capital
KRW 9.8B
Working Capital Turnover
KRW 21.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.91%
Dividend per share
KRW 0
Last Dividend
KRW 120

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
29.9%
1Y total return
257.96%
200-day SMA
26,859.6
3Y total return
63.64%
50-day SMA
38,546
50-day SMA vs 200-day SMA
50over200
5Y total return
75%
All Time High
57,800
All Time High Change
-56.4%
All Time High Date
2026-03-19
All Time Low
2,410
All Time Low Change
945.64%
All Time Low Date
2011-03-21
ATR
3,215.8
Beta
1.97
Beta1y
1.17
Beta2y
1.1
Ch YTD
-8.7
High
25,700
High52
57,800
High52 Date
2026-03-19
High52ch
-56.4%
Low
23,850
Low52
6,850
Low52 Date
2025-05-08
Low52ch
267.88%
Ma50ch
-34.62%
Price vs 200-day SMA
-6.18%
RSI
34.68
RSI Monthly
53.72
RSI Weekly
43.38
Sharpe ratio
1.64x
Sortino ratio
2.98
Total Return
-0.91%
Tr YTD
-8.7
Tr15y
901.74%
Tr1m
-19.23%
Tr1w
-15.58%
Tr3m
-37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
KRW -25.3B
Operating margin
-25.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
8,753,119%
Net Borrowing
5,874,867,390
Shares Insiders
24.87%
Shares Institutions
7.26%
Shares Out
14,261,367
Shares Qo Q
3.07%
Shares Yo Y
0.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
KRW -25.8B
Average Volume
259,163.45x
Bv Per Share
4,979.8
CAPEX
KRW -2.3B
Ch10y
27.27
Ch15y
840.3
Ch1m
-19.23
Ch1w
-15.58
Ch1y
258
Ch3m
-37
Ch3y
63.64
Ch5y
75
Ch6m
-13.1
Change
8.39%
Change From Open
0.6
Close
23,250
Days Gap
7.74
Depreciation Amortization
4,949,562,000
Dollar Volume
8,316,655,200
Earnings Date
2026-05-15
EBIT
KRW -25.3B
EBITDA
KRW -20.4B
EPS
KRW -2,097
F Score
3
FCF
KRW -25.8B
FCF EV Yield
-6.68x
FCF Per Share
KRW -1,812
Financing CF
41,745,514,270
Fiscal Year End
September
Founded
1,990
Income Tax
KRW 1.3B
Investing CF
-7,301,391,460
Is Primary Listing
1
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Ma150
32,737.1
Ma150ch
-23.02%
Ma20
31,370
Ma20ch
-19.67%
Net CF
10,377,636,980
Next Earnings Date
2026-05-15
Open
25,050
Position In Range
72.97
Ppne
41,745,738,050
Price Date
2026-05-08
Ptbv Ratio
5.1
Relative Volume
1.27x
Revenue
100,169,561,340x
SBC By Revenue
0x
Share Based Comp
3,610,000
Tax By Revenue
1.34x
Tr6m
-13.1%
Volume
330,026
Z Score
1.28
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/042520 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/042520 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+258.0%
S&P 500 1Y: n/a
3Y total return
+63.6%
S&P 500 3Y: n/a
5Y total return
+75.0%
S&P 500 5Y: n/a
10Y total return
+29.9%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/042520?

Insider, institutional, and short-interest positioning.

Institutional ownership
+7.3%
Share of float held by funds and institutions
Insider ownership
+24.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.9%
Negative means the company is buying back shares.
Technical

KOSDAQ/042520 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
34.7
Neutral momentum band
Price vs 200-day MA
-6.2%
50/200-day relationship not available
Beta (5Y)
1.97
More volatile than the market
Sharpe ratio
1.64
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/042520

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/042520 stock rating?

kosdaq/042520 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/042520 analysis?

The full report lives at /stocks/kosdaq/042520/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/042520?

The latest report frames kosdaq/042520 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/042520 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

kosdaq/042520 stock profile: metrics, valuation and analysis | StockMarketAgent.AI